Scientists have identified nanoparticles that latch onto and destroy virus membranes, opening new possibilities for antiviral ...

The antiviral combination of nirmatrelvir and ritonavir (brand name Paxlovid) is an effective treatment for people with COVID ...

The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B ...

A new way to neutralize coronavirus and other membrane-surrounded viruses has been discovered by researchers from the Swedish ...

In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients ...

New research showed some long COVID patients get symptom relief by taking an extended course of Paxlovid. Data are ...

In addition, antivirals are often only effective against ... “Vigilant will produce new compounds that will significantly improve our preparedness for future pandemics," says Pöhlmann.

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Antiviral drugs commonly used to treat non-severe influenza appeared to have little or no effect on key clinical ...

Complementary discoveries have the potential to enhance treatment options for antibiotic-resistant infections. Researchers at ...

The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it infects cells. Currently, no approved treatments exist.